Publication:
Therapeutics of bortezomib, carfilzomib, and ixazomib in proteases-induced cancer

dc.contributor.authorMustafa Gokce
dc.contributor.authorMuhammed Yunus Bektay
dc.contributor.authorEray Metin Guler
dc.contributor.institutionauthorGÜLER, ERAY METİN
dc.contributor.institutionauthorGÖKÇE, MUSTAFA
dc.contributor.institutionauthorBEKTAY, MUHAMMED YUNUS
dc.date.accessioned2026-10-25T13:39:12Z
dc.date.issued2025-01-01
dc.identifier.doi10.1016/b978-0-443-26635-5.00041-9
dc.identifier.scopus2-s2.0-105036919190
dc.identifier.urihttps://doi.org/10.1016/b978-0-443-26635-5.00041-9
dc.identifier.urihttps://hdl.handle.net/20.500.12645/42734
dc.language.isoen
dc.publisherElsevier BV
dc.rightsclosedAccess
dc.sourceOpenAire
dc.titleTherapeutics of bortezomib, carfilzomib, and ixazomib in proteases-induced canceren
dc.typePart of book or chapter of book
dspace.entity.typePublication
local.indexed.atScopus
relation.isAuthorOfPublication68927a51-77a5-4d08-8370-23b470160061
relation.isAuthorOfPublicationb0ea52ee-0cf8-4f47-beb1-9f32f39d8171
relation.isAuthorOfPublication4381d351-4283-4aac-aaa9-56ba24c96613
relation.isAuthorOfPublication.latestForDiscovery68927a51-77a5-4d08-8370-23b470160061

Files